Declining Profits for Legacy Products? An OEM's "Cost Reduction & Efficiency" Formula Re-engineering Solution

Legacy Product Profit Decline: It's Not a Shrinking Market—It's a Shifting Cost Structure

According to McKinsey's The State of Fashion: Beauty 2025, the global beauty industry has maintained 7% annual growth (2022–2024), yet 68% of brands report margin compression as their top operational challenge in 2025 . Concurrently, premium skincare products saw an average price increase of 11% between May 2024 and May 2025, driven by raw material inflation and supply chain volatility .

Blind price cuts erode brand equity; absorbing costs strains cash flow. The OEM breakthrough point isn't "squeezing processing fees"—it's Formula Re-engineering: using scientific substitution, process optimization, and supply chain synergy to achieve "cost reduction without efficacy loss, efficiency gains without risk increase."

This article, grounded in 2024–2025 verified data, breaks down 4 actionable re-engineering pathways to help brands increase single-SKU gross margins by 8–15% without triggering full regulatory re-filing.

Four Re-engineering Pathways: Data-Driven Structural Cost Reduction & Efficiency

Pathway 1: Synergistic Ingredient Substitution (Reduce Active Ingredient Procurement Costs by 30–40%)

Pain Point: Legacy products rely on single high-cost actives (e.g., high-purity VC, imported peptides) with volatile pricing and oxidation instability.

Re-engineering Strategy: Adopt a "core active + penetration enhancer/botanical synergy" mechanism loop. Through transdermal synergy and antioxidant protection, safely reduce single-ingredient loading while maintaining efficacy.

Verified Data: niacinamide paired with carnosine/panthenol enhances stratum corneum penetration efficiency by 2.3×; single-ingredient loading can be reduced by 35% while maintaining equivalent clinical scoring .

Implementation Case: An anti-aging serum replaced 10% pure VC with "5% VC derivative + 1% ergothioneine + 0.5% curcuma root extract." Raw material costs decreased 38%, while in vitro ORAC antioxidant values increased 12%, with unchanged regulatory efficacy claims.

Pathway 2: Process & Dosage Form Optimization (Reduce Processing Time by 25%, Energy Consumption by 18%)

Pain Point: Traditional high-temperature emulsification/neutralization processes are energy-intensive, degrade heat-sensitive actives, and increase batch failure rates due to stability fluctuations.

Re-engineering Strategy: Implement "cold-process emulsification + microencapsulation sustained-release" or "preservative-free polyol systems" to optimize rheological parameters and preservation architecture.

Verified Data: J. Cosmet. Dermatol. reported that cold-process emulsification increased heat-sensitive active retention from 68% to 95%, controlled in-line pH fluctuation within ±0.25, and reduced batch scrap rates to 0.6% .

Pathway 3: Packaging Lightweighting & Mono-material Design (Reduce Per-Unit Packaging Costs by 15–20%)

Pain Point: Legacy packaging features complex structures and mixed materials, driving high mold costs, low recyclability, and disproportionate logistics/warehousing expenses.

Re-engineering Strategy: Implement "structural weight reduction + Mono-material all-plastic design + centralized procurement" to simultaneously meet eco-compliance and channel display requirements.

Verified Data: NielsenIQ (2025) reports that 15% packaging weight reduction lowers per-unit logistics costs by 13% and carbon footprint by 10%; mono-material recyclable structures achieve +21% terminal shelf placement rates in 2025 . The global cosmetic packaging market is valued at $53.2 billion in 2024, projected to reach $88.6 billion by 2035, with lightweighting as a key growth driver .

Implementation Case: A toner replaced glass bottles with "PETG lightweight bottle + same-material pump," reducing per-unit packaging costs by 19%, achieving 100% drop-test pass rates, and passing EU PPWR pre-compliance assessment.

Pathway 4: Data-Driven Micro-Adjustment Validation (Compress Regulatory Cycle to 12–18 Business Days)

Pain Point: Brands fear formula adjustments triggering re-filing requirements, extending time-to-market.

Re-engineering Strategy: Adjusting excipients/processes/non-core active ratios without altering product safety or core efficacy claims qualifies for streamlined notification updates.

Re-engineering Implementation Pathway

Phase	Timeline	Key Actions
1. Cost Structure Diagnostic	W1-2	BOM audit + competitive benchmarking + margin modeling
2. Formula Simulation & Re-engineering	W3-4	Ingredient substitution + process optimization + rheology/in vitro mapping
3. Pilot Testing & Sensory Validation	W5-6	blind testing + accelerated stability + compatibility validation
4. Regulatory Update & Scale-up	W7-8	Simplified change notification + pilot production + channel rollout

Cost Reduction Isn't "Downgrading"—It's "Structural Optimization"

The essence of legacy product margin decline is static formulations failing to match dynamic cost structures and channel rules. The core value of OEM partners isn't "formula execution"—it's using formulation engineering + supply chain data to enable scientific, structural cost optimization: synergistic actives, efficient processes, lightweight packaging, and proactive compliance.

Are you seeking a trusted partner to launch or scale your skin care line? At Deva Skincare,we specialize in developing safe formulations that combine barrier science with clean, compliant manufacturing.

Our R&D team and certified production facilities deliver turnkey OEM/ODM solutions tailored to your target market’s regulatory and consumer expectations.

By collaborating with Deva Skincare, you gain access to industry-leading expertise and innovative formulations that set your brand apart in the competitive global market. Contact us today to discover how we can help you succeed.